M61.119
Myositis ossificans progressiva, unspecified shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Myositis ossificans progressiva, also known as progressive calcification of muscle tissue, is a rare condition characterized by abnormal bone formation within muscles, tendons, or soft tissues. When this condition affects the shoulder, it can lead to pain, reduced mobility, and impairments in daily activities. The ICD-10 code M61.119 specifically identifies this condition when it involves the shoulder without specifying a more detailed location or cause. This condition is often linked to trauma or injury but can sometimes occur without an obvious cause. It is essential to understand this condition to recognize its symptoms and explore management strategies, although medical consultation is necessary for personalized diagnosis and care.
Causes & Symptoms
Clinical Causes: Trauma or injury to the shoulder muscle or soft tissue, such as fractures, sprains, or surgical procedures Repetitive muscle injury or overuse of the shoulder area Genetic predispositions or rare hereditary conditions In some cases, no identifiable cause is found, suggesting idiopathic origins
Key Symptoms: Pain localized in the shoulder area, especially following injury or physical activity Swelling or a palpable lump within the soft tissues of the shoulder Restricted movement or stiffness, making shoulder motions difficult Tenderness around the affected area Possible redness or warmth if inflammation is present Progressive decrease in shoulder strength and range of motion over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and imaging tests. Doctors typically perform the following assessments: - **Medical history review:** Focuses on recent injuries, surgeries, or repetitive activities involving the shoulder - **Physical examination:** Checks for swelling, tenderness, core strength, and range of motion - **Imaging studies:** - *X-ray:* Reveals abnormal bone formation within soft tissues - *MRI:* Provides detailed images of soft tissue structures and the extent of ossification - *Computed tomography (CT):* Offers precise visualization of calcifications and ossification patterns Laboratory tests are generally not required but can help rule out other conditions, such as infections or neoplastic processes.
Treatment Protocols: Managing myositis ossificans progressiva in the shoulder typically involves a multidisciplinary approach. Treatment options may include: - **Rest and activity modification:** To prevent aggravating the condition - **Physical therapy:** Focused on gentle stretching and range-of-motion exercises to maintain joint flexibility - **Medications:** Such as nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - **Surgical intervention:** In some cases, surgical removal of ossified tissue may be considered if it causes significant functional impairment or persistent pain - **Monitoring:** Regular imaging to track disease progression and ossification patterns Early diagnosis and appropriate management can help improve shoulder function and reduce the risk of complications. However, treatment should always be guided by a healthcare professional familiar with the condition.
Clinical Advice & FAQs
Billing Guidance
Is M61.119 a billable ICD-10 code?
Yes, M61.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M61.119?
Clinical documentation must specify the nature of Myositis ossificans progressiva, unspecified shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference